CIK 0001628171 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq, Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 35.4 M | ||
| Net income (USD) | -108.2 M | -47.7 M | ||
| Diluted EPS (USD/shares) | -5.95 | -3.08 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-13 | 8-K | 8-K items 2.03,8.01 | 2026-10-08 |
| 2026-10-01 | 4 | 4 | 2026-09-29 |
| 2026-09-29 | 4 | 4 | 2026-09-25 |
| 2026-09-29 | 144 | 144 | |
| 2026-09-28 | 4 | 4 | 2026-09-24 |
| 2026-09-25 | 144 | 144 | |
| 2026-09-24 | 4 | 4 | 2026-09-22 |
| 2026-09-24 | 144 | 144 | |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 144 | 144 | |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 |
Forms on file (last 1,000): 4 372, 144 176, 8-K 71, SC 13G/A 30, 3 26, 10-Q 20, SC 13G 17, SCHEDULE 13G/A 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=RVMD (0.002 USD), /gw/filings/filings?ticker=RVMD&form=8-K, /gw/filings/facts?ticker=RVMD&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange